Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Decitabine × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 24 Myelodysplastic Syndromes 13 Leukemia, Myelomonocytic, Chronic 7 Leukemia 5 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Monocytic, Acute 2 Thrombocythemia, Essential 1 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Solid Tumor 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms 1 Myeloid Malignancies 1 Lymphodepleting Chemotherapy 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia, Basophilic, Acute 1 Human Papillomavirus-Negative Neck Squamous Cell Carcinoma 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Anemia, Refractory 1 Accelerated Phase Myeloproliferative Neoplasm 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡